EDGC, known as Eone Diagnomics Genome Center, is a leading global healthcare company established in 2013, which went public on the KOSDAQ in 2018. Specializing in genetic analysis and EDGC-SCAN liquid biopsy diagnostics, EDGC offers a wide range of services aimed at personalized disease prevention and healthcare management. Their range of cutting-edge services includes non-invasive prenatal testing, newborn genetic screening, personalized health management, and predictive tests for various diseases.

By analyzing your genetic information, EDGC can help you proactively manage your health and well-being. With a focus on precision medicine and bioinformatics, EDGC is at the forefront of revolutionizing the healthcare industry. Embrace a healthier future and design your life with your DNA at EDGC.

Trust the experts in genetic analysis and embark on a journey towards personalized healthcare and a better tomorrow